Topic Guide
What Is Ovulation tracking?
Ovulation tracking is a subject covered in depth across 1 podcast episode in our database. Below you'll find key concepts, expert insights, and the top episodes to listen to — all distilled from hours of conversation by leading experts.
Key Concepts in Ovulation tracking
Amh (anti-müllerian hormone) test
A blood test that measures the number of eggs remaining in a woman's ovaries (ovarian reserve), secreted by granulosa cells surrounding each follicle. It is a crucial marker for understanding one's reproductive timeline and should be accessible to all women considering future children, as it provides impactful knowledge for life planning and potential early intervention for underlying health issues.
Egg quality vs. ovarian reserve
Egg quality refers to the genetic normalcy and competency of an egg (its ability to respond to hormones, mitochondrial health, correct chromosome positioning), which primarily declines with age and metabolic health. Ovarian reserve, measurable by AMH, refers to the sheer number of eggs remaining in the ovaries. This distinction is vital because while quantity can be measured, quality is largely inferred by age and general health.
Fecundability
The probability of pregnancy per month for couples trying to conceive naturally. This metric varies significantly with age, with rates dropping from 20% per month at age 30 to 3% per month at age 40 and beyond. It highlights the biological reality of age-related fertility decline, even if the numbers are never zero.
Luteal phase defect
The first stage of an ovulation disorder, characterized by a shortened luteal phase (less than 11 days) where the body doesn't produce progesterone long enough, even if cycles appear regular. Tracking ovulation helps identify this early red flag, which can indicate miscommunication between the brain and ovary and warrant further investigation of underlying issues like thyroid, prolactin, or PCOS.
Hormone augmentation vs. replacement
A reframing of hormone therapy from strictly 'replacement' (only for severe deficiencies) to 'augmentation' or 'supplementation' where individuals can optimize their hormone levels within the normal range to alleviate symptoms and improve well-being. This approach advocates for greater patient autonomy and proactive health management, moving beyond restrictive diagnostic cut-offs.
What Experts Say About Ovulation tracking
- 1.Fertility and hormone health are strong correlates of general health and longevity; infertility itself is an early warning sign for increased risks of metabolic syndrome, cancer, heart attack, stroke, and early death.
- 2.The AMH (Anti-Müllerian Hormone) test, costing around $79 out-of-pocket, is crucial for assessing ovarian reserve (egg count) for any woman considering future pregnancy, despite medical guidelines suggesting it's only for those with infertility.
- 3.Egg quality (genetic normalcy and mitochondrial health) declines with age due to accumulated wear and tear and metabolic health changes, but AMH measures egg quantity, not quality.
- 4.The traditional definition of infertility as a 'failure' (e.g., 12 months of trying to conceive or 6 months if 35+) delays crucial testing and intervention, hindering timely treatment for many.
- 5.Hormone replacement therapy (HRT) should shift towards 'hormone augmentation' to allow women to optimize hormone levels within the normal range to alleviate symptoms and improve well-being, even in perimenopause.
- 6.Prior successful pregnancy statistically offers a protective benefit for future pregnancies, maintaining an 18-20% chance per month until age 37, but secondary infertility is a real possibility.